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Extrinsic extracellular DNA leads to
biofilm formation and colocalizes with
matrix polysaccharides in the human
pathogenic fungus Aspergillus fumigatus
by Shopova, I., Bruns, S., Thywissen,
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ASPERGILLOSIS IN CLINICAL CONTEXT
Aspergillosis is a fungal infection that
can assume a broad spectrum of clinical
forms depending on immune status and
the presence of underlying lung diseases,
ranging from allergic bronchopul-
monary aspergillosis to aspergilloma
and also to the invasive aspergillosis
forms that are a major cause of mor-
tality in severely immunocompromised
patients. Pulmonary aspergillosis fol-
lows the inhalation of airborne conidia
of Aspergillus fumigatus, and pre-existing
conditions such as pulmonary functional
abnormalities such as cystic fibrosis or
chronic obstructive pulmonary disease
provides a favorable environment for
Aspergillus colonization and biofilm for-
mation in the lungs (Zmeili and Soubani,
2007; Ramage et al., 2011). Due to its great
importance in clinical context, a better
understanding of the process in filamen-
tous growth and biofilm formation can
help to manage Aspergillus infection, espe-
cially when dealing with resistant strains
to current antifungal drugs (Arendrup,
2013).
BIOFILMS AND THE RESISTANCE TO
ANTIFUNGAL AGENTS
Biofilms can be defined as microbial
communities encased in a matrix of
extracellular adhesive polymeric sub-
stances or extracellular matrix (ECM) and
are considered as an important virulence
determinant for a pathogen. For a fungus
specie, growing as multicellular commu-
nity may confer biological advantages in
the colonization of tissues andmay also act
as barrier to external aggressions (Beauvais
et al., 2007). Biofilms have raised special
attention due to their high resistance to
antimicrobial agents that can be up to
1000-fold greater than observed for plank-
tonic cells (Tobudic et al., 2012). Previous
studies with cultures of A. fumigatusmain-
tained under static aerial conditions have
demonstrated the presence of an ECM on
the colony surface of colonial mycelia that
acts as cohesive linkage bounding hyphae
into a contiguous sheath, and this ECM
is absent when the fungus is grown under
liquid shake conditions. These colonies
encased with ECM were also found to
be extremely hydrophobic and displayed
more resistance to antifungal polyenes
amphotericin B and nystatin (Beauvais
et al., 2007). In vivo studies showed that
ECM production were also present at
the surface of hyphae of A. fumigatus in
an aspergilloma (“fungus ball”) or dur-
ing invasive aspergillosis (Loussert et al.,
2010). In the antifungal resistance con-
text, ECM may act as a physical barrier
that decreases the access of antifungals to
cells embedded in the biofilm community.
The low penetration of the drugs seems
to depend on the amount and nature of
ECM, as well as the physicochemical prop-
erties of the antifungal agents. Thus, it
was also demonstrated that the removal
of ECM from Candida albicans biofilms
reduced the survival rate of Candida
cells when treated with Amphotericin B
(Tobudic et al., 2012). The limited number
of antifungal classes for treatment of
aspergillosis brings special attention to
biofilm formation in Aspergillus infec-
tions, considering the fact that the drugs
should also be able to overcome the ECM
barrier to perform its antifungal action.
NATURE OF ASPERGILLUS BIOFILMS
AND THE INFLUENCE OF eDNA
Aspergillus ECM was initially found to
be composed of galactomannan, alpha-
1,3 glucans, melanin and other proteins
including hydrophobins (Beauvais et al.,
2007). Recently it was demonstrated the
presence of extracellular DNA (eDNA)
in A. fumigatus ECM biofilm, which was
released upon fungal autolysis (Rajendran
et al., 2013). Taking into consideration that
addition of DNAse improved in vitro activ-
ity of antifungal drugs directed to Candida
albicans biofilms (Martins et al., 2012), it
was suggested that the role of eDNA in
Candida species may be associated with:
(i) maintenance and stability of biofilms
and (ii) biofilm resistance to antifungal
drugs. Similar results were also observed
for A. fumigatus biofilms, where the treat-
ment with DNAse destabilized biofilm
architecture integrity and concomitant
treatment of biofilms with DNAse and
amphotericin B or caspofungin improved
antifungal susceptibility (Rajendran et al.,
2013). These findings together demon-
strated the important role of eDNA in
Aspergillus ECM biofilm. Further studies
exploiting the role of eDNA in biofilm
formation performed by Brakhage and
Hillman’s research group, have demon-
strated the importance of extrinsic eDNA
in inducing and shaping A. fumigatus
biofilms by adding exogenous eDNA in
an in vitro biofilm model (Shopova et al.,
2013). They also showed that eDNA
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facilitated surface adhesion of fungal
spores and also colocalized with ECM
biofilm polysaccharides, becoming part of
the ECM surrounding the biofilm cells.
The fact that exogenous eDNA stimu-
lated biofilm formation in vitro resem-
bles body’s innate immune response to
inhaled conidia, whereas the response to
conidia that manage to escape alveo-
lar macrophages includes the formation
of neutrophil extracellular traps (NETs)
which consist in masses of decondensed
chromatin decorated with antimicrobial
proteins and opsonins (McCormick et al.,
2010). Within this context, NETs are
believed to function as physical bar-
rier containing the microorganism within
the mass of chromatin, enhancing direct
contact with the antimicrobial NETs-
associated proteins, thus representing an
anti-microbial effector mechanism that
mediates killing of a wide range of
bacterial pathogens as well as C. albi-
cans (McCormick et al., 2010). However,
in vitro models with Aspergillus showed
that despite the fact that NETs forma-
tion leads to trapping the fungus con-
ferring a fungistatic effect by contain-
ing the infection, it does not represent
the major factor for killing this fungus
since NET-dependent killing of Aspergillus
hyphae was only moderated (Bruns et al.,
2010).
FUTURE PERSPECTIVES
Taken together these findings, the next
steps would include the elucidation of the
in vivo influence of NET’s eDNA produced
by lungs in Aspergillus biofilm develop-
ment, which may lead to the combination
of antifungal drugs with DNAse to manage
pulmonary aspergillosis. Further studies
could also explore the Aspergillus ECM
physicochemical features and permeabil-
ity to current antifungal drugs, and these
findings may lead to molecular improve-
ment of these drugs by conferring them
the capacity to penetrate ECM Aspergillus
biofilm and act in their respective molecu-
lar targets.
ACKNOWLEDGMENT
The authors would like to acknowledge
Prof. Anita H. Straus for critically review-
ing the manuscript.
REFERENCES
Arendrup, M. C. (2013). Update on antifungal resis-
tance in Aspergillus and Candida. Clin. Microbiol.
Infect. doi: 10.1111/1469-0691.12513. [Epub ahead
of print].
Beauvais, A., Schmidt, C., Guadagnini, S., Roux,
P., Perret, E., Henry, C., et al. (2007). An
extracellular matrix glues together the aerial-
grown hyphae of Aspergillus fumigatus. Cell.
Microbiol. 9, 1588–1600. doi: 10.1111/j.1462-
5822.2007.00895.x
Bruns, S., Kniemeyer, O., Hasenberg,M., Aimanianda,
V., Nietzsche, S., Thywissen, A., et al. (2010).
Production of extracellular traps against
Aspergillus fumigatus in vitro and in infected
lung tissue is dependent on invading neutrophils
and influenced by hydrophobinroda. PLoS
Pathog. 6:e1000873. doi: 10.1371/journal.ppat.10
00873
Loussert, C., Schmitt, C., Prevost, M. C., Balloy,
V., Fadel, E., Philippe, B., et al. (2010). In
vivo biofilm composition of Aspergillus fumigatus.
Cell. Microbiol. 12, 405–410. doi: 10.1111/j.1462-
5822.2009.01409.x
Martins, M., Henriques, M., Lopez-Ribot, J. L.,
and Oliveira, R. (2012). Addition of DNase
improves the in vitro activity of antifun-
gal drugs against Candida albicans biofilms.
Mycoses 55, 80–85. doi: 10.1111/j.1439-0507.2011.
02047.x
McCormick, A., Loeffler, J., and Ebel, F. (2010).
Aspergillus fumigatus: contours of an opportunistic
human pathogen. Cell. Microbiol. 12, 1535–1543.
doi: 10.1111/j.1462-5822.2010.01517.x
Rajendran, R., Williams, C., Lappin, D. F., Millington,
O., Martins, M., and Ramage, G. (2013).
Extracellular DNA release acts as an antifun-
gal resistance mechanism in mature Aspergillus
fumigatus biofilms. Eukaryot. Cell 12, 420–429.
doi: 10.1128/EC.00287-12
Ramage, G., Rajendran, R., Gutierrez-Correa, M.,
Jones, B., and Williams, C. (2011). Aspergillus
biofilms: clinical and industrial significance. FEMS
Microbiol. Lett. 324, 89–97. doi: 10.1111/j.1574-
6968.2011.02381.x
Shopova, I., Bruns, S., Thywissen, A., Kniemeyer,
O., Brakhage, A. A., and Hillmann, F. (2013).
Extrinsic extracellular DNA leads to biofilm
formation and colocalizes with matrix polysac-
charides in the human pathogenic fungus
Aspergillus fumigatus. Front. Microbiol. 4:141. doi:
10.3389/fmicb.2013.00141
Tobudic, S., Kratzer, C., Lassnigg, A., and Presterl,
E. (2012). Antifungal susceptibility of Candida
albicans in biofilms. Mycoses 55, 199–204. doi:
10.1111/j.1439-0507.2011.02076.x
Zmeili, O. S., and Soubani, A. O. (2007). Pulmonary
aspergillosis: a clinical update. Q. J. Med. 100,
317–334. doi: 10.1093/qjmed/hcm035
Conflict of Interest Statement: The authors declare
that the research was conducted in the absence of any
commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 27 April 2014; accepted: 12 May 2014;
published online: 30 May 2014.
Citation: Guimarães LL and Takahashi HK (2014) A
snapshot of extracellular DNA influence on Aspergillus
biofilm. Front. Microbiol. 5:260. doi: 10.3389/fmicb.
2014.00260
This article was submitted to the journal Frontiers in
Microbiology.
Copyright © 2014 Guimarães and Takahashi. This is
an open-access article distributed under the terms of the
Creative Commons Attribution License (CC BY). The
use, distribution or reproduction in other forums is per-
mitted, provided the original author(s) or licensor are
credited and that the original publication in this journal
is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which
does not comply with these terms.
Frontiers in Microbiology www.frontiersin.org May 2014 | Volume 5 | Article 260 | 2
